<DOC>
	<DOCNO>NCT00256256</DOCNO>
	<brief_summary>Type 2 diabetes mellitus , T2D disease characterize immense grow prevalence world wide increase risk myocardial infarction stroke . GLP-1 convincing effect high glucose level type 2 diabetic patient well tolerate . New animal study indicate protective effect GLP-1 brain heart . The mechanism behind yet know . The study hypothesis GLP-1 stimulate glucose-uptake brain heart independent insulin thereby exert protective effect .</brief_summary>
	<brief_title>The Effect GLP-1 Glucose Uptake Brain Heart Healthy Men</brief_title>
	<detailed_description>Type 2 diabetes mellitus , T2D disease characterize immense grow prevalence world wide . T2D associate three-fold increase cardiovascular complication ( myocardial infarction stroke ) lead significantly high morbidity mortality group patient . The prospective British Diabetes Study ( UKPDS ) show neither diet alone pharmaceutical treatment utilized ( Sulphonylurea , Metformin , Insulin ) able reduce macrovascular complication . GLP-1 ( glucagon-like-peptide-1 ) incretin convince effect glycaemia type 2 diabetic patient little risk hypoglycaemia . New research animal model show potential protective effect brain heart association ischaemic damage . The mechanism behind protective effect know . The effect native GLP-1 glucose uptake brain heart visualize fluoro-deoxy-glucose FDG-PET-scan normoglycaemia healthy young men . At time pancreatic/pituitary clamp perform . The hypothesis GLP-1 directly stimulate glucose uptake independent pancreatic hormone mechanism exert neuro- cardioprotective action . Comparisons : FDG-uptake brain heart GLP-1 infusion compare placebo .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<criteria>Healthy men Age 2050 year Caucasian BMI 2030 kg/m2 Diabetes subject 1.degree relatives Any disease clinical relevance</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>type 2 diabetes</keyword>
	<keyword>GLP-1</keyword>
	<keyword>PET</keyword>
	<keyword>brain</keyword>
	<keyword>heart</keyword>
</DOC>